We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Lenalidomide and Paclitaxel in Advanced Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01155505
Recruitment Status : Unknown
Verified September 2011 by Southern Europe New Drug Organization.
Recruitment status was:  Active, not recruiting
First Posted : July 1, 2010
Last Update Posted : September 13, 2011
Sponsor:
Collaborator:
Celgene Corporation
Information provided by (Responsible Party):
Southern Europe New Drug Organization

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2011
  Estimated Study Completion Date : March 2012